Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

337 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

NCT07284459

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • Instituto de Especialidades de la Salud Rosario - Clínica del Tórax Rosario, Santa Fe Province, Argentina
  • Centro de Investigaciones Médicas Tucumán - PPDS San Miguel de Tucumán, Tucumán Province, Argentina
  • IPR-Investigaciones en Patologías Respiratorias San Miguel de Tucumán, Tucumán Province, Argentina
  • Centro Modelo de Cardiología-Laprida 554 San Miguel de Tucumán, Tucumán Province, Argentina
View all 79 locations
View Trial Details
Recruiting

A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

NCT07516951

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • PHI University Clinic of Pulmonology and Allergology Skopje, North Macedonia
  • Premier Pulmonary Critical Care and Sleep Medicine, PA Denison, Texas, United States
  • Hannibal Regional Healthcare System, Inc. Hannibal, Missouri, United States
View Trial Details
Recruiting

Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT07687459

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Anhui Chest Hospital Hefei, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Chaoyang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 47 locations
View Trial Details
Recruiting

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

NCT07671911

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Pulmonary Specialists of The Palm Beaches Loxahatchee Groves, Florida, United States
  • Clinical Research and Associates, Inc. Miami, Florida, United States
  • Clinical Research of Gastonia (CRG) Gastonia, North Carolina, United States
  • El Paso Pulmonary Association, PA El Paso, Texas, United States
View all 19 locations
View Trial Details
Recruiting

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

NCT07230288

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Sec Clinical Research - East - Dothan - Graceland /ID# 278328 Dothan, Alabama, United States
  • Christie Clinic on University /ID# 277871 Champaign, Illinois, United States
  • Hannibal Regional Hospital /ID# 277984 Hannibal, Missouri, United States
  • Centre d'Investigation Clinique Mauricie /ID# 277949 Trois-Rivières, Quebec, Canada
View all 57 locations
View Trial Details
Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT05571059

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Biosolutions Clinical Research La Mesa, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Miami VA Health System Miami, Florida, United States
View all 20 locations
View Trial Details

Related conditions